Transarterial Embolization With or Without Chemotherapy: What Should Be the Indication for Patients With Hepatocellular Carcinoma?

J Clin Oncol. 2017 Jan 10;35(2):257-258. doi: 10.1200/JCO.2016.68.4902. Epub 2016 Oct 23.

Authors

Jian-Hong Zhong¹, Jun-Tao Tan¹, Li-Qun Li¹, Wen-Shu Wu¹, Chang Zhao¹

Affiliation

¹ Jian-Hong Zhong, Jun-Tao Tan, and Li-Qun Li, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, People's Republic of China; Wen-Shu Wu, University of Illinois College of Medicine at Chicago, Chicago, IL; and Chang Zhao, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, People's Republic of China.

PMID: 28056197
DOI: 10.1200/JCO.2016.68.4902

No abstract available

Publication types

Letter
Comment

MeSH terms

Carcinoma, Hepatocellular*
Chemoembolization, Therapeutic
Doxorubicin
Embolization, Therapeutic
Hepatic Artery
Humans
Liver Neoplasms*
Microspheres

Substances

Doxorubicin